Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? | SpringerLink
Cureus | Trial Sequential Analysis Comparing Bleeding and Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation and Acute Coronary Syndrome on Dual versus Triple Therapy | Article
Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach? - ScienceDirect
PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study... | Download Scientific Diagram
![PDF] Evaluation of the safety and efficacy of an edoxaban‐based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST‐AF](https://d3i71xaburhd42.cloudfront.net/4107965fd29bd24ad0a28eea66938425b733e805/4-TableI-1.png "PDF] Evaluation of the safety and efficacy of an edoxaban‐based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST‐AF")
PDF] Evaluation of the safety and efficacy of an edoxaban‐based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST‐AF
Adobe AudienceManager
Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter
PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study Design | Radcliffe Cardiology
PIONEER AF-PCI trial overview | Thrombosis Adviser
![Design of the PIONEER AF-PCI trial [42]. a Creatinine clearance 30-49... | Download Scientific Diagram](https://www.researchgate.net/publication/332352082/figure/fig2/AS:746553086058496@1555003534230/Design-of-the-PIONEER-AF-PCI-trial-42-a-Creatinine-clearance-30-49-mL-min-10-mg-od-b_Q640.jpg "Design of the PIONEER AF-PCI trial [42]. a Creatinine clearance 30-49... | Download Scientific Diagram")
Design of the PIONEER AF-PCI trial [42]. a Creatinine clearance 30-49... | Download Scientific Diagram
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy | Circulation
Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology
Atrial Fibrillation and PCI - ppt download
PIONEER AF-PCI: Rivaroxaban + P2Y12 Inhibitor clopidogrel ~94% or Rivaroxaban + DAPT vs. Warfarin + DAPT in Patients with Atrial
PIONEER AF-PCI - Antithrombotics in patients with AF after PCI — NERDCAT
JCM | Free Full-Text | Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials
Noacs in pci for af hoi nghi viet duc 2017
Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI | Challenges in Cardiology
The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status | tctmd.com
Xarelto® (rivaroxaban) – PIONEER
Prevention of Bleeding in Patients With Atrial Fibrillation Undergoing PCI ( PIONEER): Three May End Up Being a Crowd - Samuel A. Berkman, 2018
PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study... | Download Scientific Diagram
